139 related articles for article (PubMed ID: 11954054)
61. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
62. Recombinant shark natural antibodies to thyroglobulin.
Schluter SF; Jensen I; Ramsland PA; Marchalonis JJ
J Mol Recognit; 2005; 18(5):404-12. PubMed ID: 15954089
[TBL] [Abstract][Full Text] [Related]
63. Kinetic analysis of engineered antibody-antigen interactions.
Malmqvist M
J Mol Recognit; 1994 Mar; 7(1):1-7. PubMed ID: 7527233
[TBL] [Abstract][Full Text] [Related]
64. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
[TBL] [Abstract][Full Text] [Related]
65. Comment on "Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates".
Lucas AH; Reason DC
J Immunol; 2009 May; 182(9):5160-1. PubMed ID: 19380755
[No Abstract] [Full Text] [Related]
66. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
67. Biophysical properties of human antibody variable domains.
Ewert S; Huber T; Honegger A; Plückthun A
J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
[TBL] [Abstract][Full Text] [Related]
68. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
Houimel M; Dellagi K
J Virol Methods; 2009 Nov; 161(2):205-15. PubMed ID: 19559727
[TBL] [Abstract][Full Text] [Related]
69. Antibodies exhibit multiple paratope states influencing V
Fernández-Quintero ML; Pomarici ND; Math BA; Kroell KB; Waibl F; Bujotzek A; Georges G; Liedl KR
Commun Biol; 2020 Oct; 3(1):589. PubMed ID: 33082531
[TBL] [Abstract][Full Text] [Related]
70. Dissecting the alternatively folded state of the antibody Fab fragment.
Feige MJ; Simpson ER; Herold EM; Bepperling A; Heger K; Buchner J
J Mol Biol; 2010 Jun; 399(5):719-30. PubMed ID: 20434459
[TBL] [Abstract][Full Text] [Related]
71. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
72. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
Zhang Z; Shah B
Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
[TBL] [Abstract][Full Text] [Related]
73. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
Jespers L; Schon O; James LC; Veprintsev D; Winter G
J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
[TBL] [Abstract][Full Text] [Related]
74. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Barrios Y; Jirholt P; Ohlin M
J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
[TBL] [Abstract][Full Text] [Related]
75. [Construction and preliminary panning of Fab phage display antibody library against respiratory syncytial virus].
Wang ZH; Zhang GC; Li AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):681-5. PubMed ID: 19102829
[TBL] [Abstract][Full Text] [Related]
76. The folding pathway of the antibody V(L) domain.
Simpson ER; Herold EM; Buchner J
J Mol Biol; 2009 Oct; 392(5):1326-38. PubMed ID: 19647749
[TBL] [Abstract][Full Text] [Related]
77. Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding.
Kirkham PM; Mortari F; Newton JA; Schroeder HW
EMBO J; 1992 Feb; 11(2):603-9. PubMed ID: 1537339
[TBL] [Abstract][Full Text] [Related]
78. Purification of reduced and alkylated antibody subunits.
Sun M; Paul S
Methods Mol Biol; 1995; 51():111-22. PubMed ID: 7581690
[No Abstract] [Full Text] [Related]
79. Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma.
Kotlan B; Simsa P; Foldi J; Fridman WH; Glassy M; McKnight M; Teillaud JL
Hum Antibodies; 2003; 12(4):113-21. PubMed ID: 15156099
[TBL] [Abstract][Full Text] [Related]
80. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
